Impact of serosal involvement/extramural growth on the risk of synchronous and metachronous peritoneal spread in gastrointestinal stromal tumors: Proposal for a macroscopic classification of GIST

International Journal of Clinical and Experimental Pathology

Volumn 5, Issue 1, 2012, Pages 12-22

  Agaimy, Abbas ^a   Vassos, Nikolaos ^a   Wünsch, Peter H ^b   Hohenberger, Werner ^a   Hartmann, Arndt ^a   Croner, Roland S ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b City Hospital Nürnberg   (Germany)

Author keywords

Gastrointestinal stromal tumors; GIST; Macroscopic classification; Peritoneal spread; Serosa penetration

Indexed keywords

ADULT; AGED; ARTICLE; CLASSIFICATION; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GASTROINTESTINAL TUMOR; HUMAN; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; PERITONEUM TUMOR; RETROSPECTIVE STUDY; RISK FACTOR; SEROSA;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; SEROUS MEMBRANE; YOUNG ADULT;

EID: 84856694077     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 2006; 23: 70-83.
2. Nilsson B, Bümming P, Meis-Kindblom JM, Odén A, Dortok A, Gustavsson B, Sablinska K, Kindblom LG. Gastrointestinal stromal tumors: The incidence, prevalence, clinical course and prognostication in the preimatinib era. A population-based study in Western Sweden. Cancer 2005; 103: 821-829.
3. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000; 231: 51-58.
4. Dematteo RP, Gold JS, Saran L, Gönen M, Liau KH, Maki RG, Singer S, Besmer P, Brennan MF, Antonescu CR. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST). Cancer 2008; 112: 608-615.
5. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O'Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 2002; 33: 459-465.
6. Gold JS, Gönen M, Gutiérrez A, Broto JM, García-del-Muro X, Smyrk TC, Maki RG, Singer S, Brennan MF, Antonescu CR, Donohue JH, DeMatteo RP. Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. Lancet Oncol 2009; 10: 1045-1052.
7. Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol 2008; 39: 1411-1419.
8. Joensuu H. Predicting recurrence-free survival after surgery for GIST. Lancet Oncol 2009; 10: 1025.
9. Woodall CE 3rd, Brock GN, Fan J, Byam JA, Scoggins CR, McMasters KM, Martin RC 2nd. An evaluation of 2537 gastrointestinal stromal tumors for a proposed clinical staging system. Arch Surg 2009; 144: 670-678.
10. Gumurdulu D, Erdogan S, Kayaselcuk F, Seydaoglu G, Parsak CK, Demircan O, Tuncer I. Expression of COX-2, PCNA, Ki-67 and p53 in gastrointestinal stromal tumors and its relationship with histopathological parameters. World J Gastroenterol 2007; 13: 426-431.
11. Haller F, Cortis J, Helfrich J, Cameron S, Schüler P, Schwager S, Gunawan B, Füzesi L, Agaimy A. Epithelioid/mixed phenotype in gastrointestinal stromal tumors (GISTs) with KIT mutation from the stomach is associated with accelerated passage of late phases of the cell cycle and shorter disease-free survival. Mod Pathol 2011; 24: 248-255.
12. Haller F, Agaimy A, Cameron S, Beyer M, Gunawan B, Happel N, Langer C, Ramadori G, von Heydebreck A, Füzesi L. Expression of p16INK4A in gastrointestinal stromal tumours (GISTs): two different forms exist which independently correlate with poor prognosis. Histopathology 2010; 56: 305-318.
13. Hou YY, Grabellus F, Weber F, Zhou Y, Tan YS, Li J, Shen KT, Qin J, Sun YH, Qin XY, Bockhorn M, Gerken G, Broelsch CE, Frilling A. Impact of KIT and PDGFRA gene mutations on prognosis of patients with gastrointestinal stromal tumors after complete primary tumor resection. J Gastrointest Surg 2009; 13: 1583-1592.
14. Gunawan B, Bergmann F, Höer J, Langer C, Schumpelick V, Becker H, Füzesi L. Biological and clinical significance of cytogenetic abnormalities in low-risk and high-risk gastrointestinal stromal tumors. Hum Pathol 2002; 33: 316-321.
15. Sanchez Hidalgo JM, Rufian Peña S, Ciria Bru R, Naranjo Torres A, Muñoz Casares C, Ruiz Rabelo J, Briceño Delgado J. Gastrointestinal stromal tumors (GIST): a prospective evaluation of risk factors and prognostic scores. J Gastrointest Cancer 2010; 41: 27-37.
16. Vallböhmer D, Marcus HE, Baldus SE, Brabender J, Lurje G, Drebber U, Metzger R, Hölscher AH, Schneider PM. Comparative analysis of four histopathological classification systems to discriminate benign and malignant behaviour in gastrointestinal stromal tumors. Anticancer Res 2008; 28: 367-372.
17. Elshenawy YM, Ganote CE, Al-Abbadi MA. Fatal abdominal sarcomatosis secondary to gastrointestinal stromal tumor with bland histology. Saudi Med J 2009; 30: 1469-1472.
18. Zhang L, Smyrk TC, Young WF Jr, Stratakis CA, Carney JA. Gastric stromal tumors in Carney triad are different clinically, pathologically, and behaviorally from sporadic gastric gastrointestinal stromal tumors: findings in 104 cases. Am J Surg Pathol 2010; 34: 53-64.
19. Rutkowski P, Nowecki ZI, Michej W, Debiec-Rychter M, Woźniak A, Limon J, Siedlecki J, Grzesiakowska U, Kakol M, Osuch C, Polkowski M, Głuszek S, Zurawski Z, Ruka W. Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumor. Ann Surg Oncol 2007; 14: 2018-2027.
20. Hohenberger P, Ronellenfitsch U, Oladeji O, Pink D, Ströbel P, Wardelmann E, Reichardt P. Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour. Br J Surg 2010; 97: 1854-1859.
21. Vallböhmer D, Marcus HE, Baldus SE, Brabender J, Drebber U, Metzger R, Hölscher AH, Schneider PM. Serosal penetration is an important prognostic factor for gastrointestinal stromal tumors. Oncol Rep 2008; 20: 779-783.
22. Agaimy A, Wünsch PH, Hofstaedter F, Blaszyk H, Rümmele P, Gaumann A, Dietmaier W, Hartmann A. Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations. Am J Surg Pathol 2007; 31: 113-120.
23. Agaimy A, Wünsch PH. Gastrointestinal stromal tumours: a regular origin in the muscularis propria, but an extremely diverse gross presentation. A review of 200 cases to critically re-evaluate the concept of so-called extra -gastrointestinal stromal tumours. Langenbecks Arch Surg 2006; 391: 322-329.
24. Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors presenting as omental masses-a clinicopathologic analysis of 95 cases. Am J Surg Pathol 2009; 33: 1267-1275.
25. Agaimy A. Gastrointestinal stromal tumors (GIST) from risk stratification systems to the new TNM proposal: more questions than answers? A review emphasizing the need for a standardized GIST reporting. Int J Clin Exp Pathol 2010; 3: 461-471.
26. Rubin BP, Blanke CD, Demetri GD, Dematteo RP, Fletcher CD, Goldblum JR, Lasota J, Lazar A, Maki RG, Miettinen M, Noffsinger A, Washington MK, Krausz T. Cancer Committee, College of American Pathologists. Protocol for the examination of specimens from patients with gastrointestinal stromal tumor. Arch Pathol Lab Med 2010; 134: 165-170.
27. Sobin LH, Wittekind Ch (eds.). International union against cancer (UICC). TNM classification of malignant tumours. 7th ed. New York: Wiley; 2010.
28. Goh BK, Chow PK, Kesavan SM, Yap WM, Chung YF, Wong WK. Outcome after curative resection of large (≥10 cm) gastric gastrointestinal stromal tumors: how frequent is adjacent organ involvement and is concomitant distal pancreatectomy necessary? J Gastrointest Surg 2010; 14: 607-613.